Publication

This paper examines why the access to antiretroviral medicines (ARVs) for AIDS treatment in Africa creates complications for both local and global governance. The authors describe how local modalities of AIDS treatment are governed by the context of global trade through the implementation of patents on medicines in the World Trade Organisation (WTO), and within the context of global aid through development assistance. Particular emphasis is given to how the discrepancies between international and national priorities on the one hand, and aid and trade on the other, impact the specific access to ARVs for AIDS infected people in Uganda.